Concepedia

Author

Dimitrios Galanakis

University College London

Also Known As

D Galanakis, D. GALANAKIS, D. Galanakis, Dimitrios Galanakis, Galanakis, D., Galanakis, Dimitrios

69

Publications

1.2K

Citations

22

H-Index

71

Concepts

All Affiliations

University College LondonAristotle University of ThessalonikiUniversity of Illinois Urbana-ChampaignNational and Kapodistrian University of AthensLouisiana State University
DG

About

Dimitrios Galanakis is an author at University College London specializing in pharmacology, natural sciences, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Natural Sciences

12

12

488

2

Medicine

10

10

377

3

Engineering

7

7

234

4

Social Sciences

1

1

13

5

Allergy

1

1

44

Dimitrios Galanakis

×

30

Publications

1.1K

Citations

21

H-Index

YearCitations

Synthesis, Molecular Modeling, and Pharmacological Testing of Bis-Quinolinium Cyclophanes:  Potent, Non-Peptidic Blockers of the Apamin-Sensitive Ca<sup>2+</sup>-Activated K<sup>+</sup>Channel

Joaquín M. Campos Rosa, Dimitrios Galanakis, Alessandro Piergentili,

Journal of Medicinal Chemistry

1999

94

Bis-Quinolinium Cyclophanes:  6,10-Diaza-3(1,3),8(1,4)-dibenzena-1,5(1,4)- diquinolinacyclodecaphane (UCL 1684), the First Nanomolar, Non-Peptidic Blocker of the Apamin-Sensitive Ca<sup>2+</sup>-Activated K<sup>+</sup> Channel

Joaquín M. Campos Rosa, Dimitrios Galanakis, C. Robin Ganellin,

Journal of Medicinal Chemistry

1998

78

Synthesis and pharmacological evaluation of amide conjugates of NSAIDs with L-cysteine ethyl ester, combining potent antiinflammatory and antioxidant properties with significantly reduced gastrointestinal toxicity

Dimitrios Galanakis, Angeliki P. Kourounakis, Karyophyllis C. Tsiakitzis,

Bioorganic & Medicinal Chemistry Letters

2004

77

Synthesis and pharmacological evaluation of novel derivatives of anti-inflammatory drugs with increased antioxidant and anti-inflammatory activities

Angeliki P. Kourounakis, Dimitrios Galanakis, Karyofillis C. Tsiakitzis,

Drug Development Research

1999

74

Higher order corrections to effective low-energy theories for strongly correlated electron systems

A. L. Chernyshev, Dimitrios Galanakis, Philip Phillips,

Physical Review B

2004

58

Bis-Quinolinium Cyclophanes:  8,14-Diaza-1,7(1,4)-diquinolinacyclotetradecaphane (UCL 1848), a Highly Potent and Selective, Nonpeptidic Blocker of the Apamin-Sensitive Ca<sup>2+</sup>-Activated K<sup>+</sup> Channel

Jianqing Chen, Dimitrios Galanakis, C. Robin Ganellin,

Journal of Medicinal Chemistry

2000

54

Proximity of the Superconducting Dome and the Quantum Critical Point in the Two-Dimensional Hubbard Model

Shuxiang Yang, Herbert F. Fotso, Shi-Quan Su,

Physical Review Letters

2011

52

Quantum criticality due to incipient phase separation in the two-dimensional Hubbard model

Ehsan Khatami, Karlis Mikelsons, Dimitrios Galanakis,

Physical Review B

2010

50

Reduction of gastrointestinal toxicity of NSAIDs via molecular modifications leading to antioxidant anti-inflammatory drugs

Panos N. Kourounakis, Karyofyllis Tsiakitzis, Angeliki P. Kourounakis,

Toxicology

2000

44

Synthesis and Structure-Activity Relationships of Dequalinium Analogs as K+ Channel Blockers. Investigations on the Role of the Charged Heterocycle

Dimitrios Galanakis, Carole Davis, Benedicto Del Rey Herrero,

Journal of Medicinal Chemistry

1995

38

Page 1